What are the major opportunities in the Liquid Biopsy For Cancer Diagnostics market? What are the strategies for the Liquid Biopsy For Cancer Diagnostics market?

For detailed insights on the major opportunities and strategies in the Liquid Biopsy For Cancer Diagnostics market, Read More

How does the Liquid Biopsy For Cancer Diagnostics market relate to the overall economy and other similar markets?

For detailed insights on Liquid Biopsy For Cancer Diagnostics's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Liquid Biopsy For Cancer Diagnostics market growth? SWOT analysis of the Liquid Biopsy For Cancer Diagnostics market.

For detailed insights on the key dynamics influencing the Liquid Biopsy For Cancer Diagnostics market growth and SWOT analysis of the Liquid Biopsy For Cancer Diagnostics industry, Read More

Liquid Biopsy For Cancer Diagnostics Market Global Report 2026 Market Report Infographic Image

Item added to cart!

Published : February 2026

Pages : 200

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Liquid Biopsy For Cancer Diagnostics Market Report 2026

Name: Liquid Biopsy For Cancer Diagnostics Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Type (Product, Services), By Sample (Blood, Urine, Saliva), By Cancer (Lung Cancer, Breast Cancer, Colon Cancer, Other Cancers), By End-User (Hospitals, Diagnostic Centers, Other End-Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Liquid Biopsy For Cancer Diagnostics Market Overview

• Liquid Biopsy For Cancer Diagnostics market size has reached to $10.75 billion in 2025

• Expected to grow to $22.99 billion in 2030 at a compound annual growth rate (CAGR) of 16.4%

• Growth Driver: Rising Tide Of Cancer Is Anticipated To Fuels The Liquid Biopsy For Cancer Diagnostics Market Growth

• Market Trend: Innovative Liquid Biopsy Solutions Revolutionizing Cancer Detection and Research

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Liquid Biopsy For Cancer Diagnostics Market?

Liquid biopsy for cancer diagnostics is a less invasive method than traditional tissue biopsies, which include evaluating genetic material or biomarkers discovered in a patient's blood or other bodily fluids to find and monitor the presence of cancer. It is commonly used for screening and identifying non-small cell lung cancer (NSCLC) and as a gastrointestinal and ovarian liquid biopsy for cancer diagnostics.

The main types of liquid biopsy for cancer diagnostics include products and services. A product refers to any procedure, method, or tool created or used to identify a sickness or illness in people or other vertebrate animals. Various types of samples are involved, such as blood, urine, and saliva. The various types of cancer include lung cancer, breast cancer, colon cancer, and others, which are used by several end-users, including hospitals, diagnostic centers, and others.

Liquid Biopsy For Cancer Diagnostics Market Global Report 2026 Market Report bar graph

What Is The Liquid Biopsy For Cancer Diagnostics Market Size and Share 2026?

The liquid biopsy for cancer diagnostics market size has grown rapidly in recent years. It will grow from $10.75 billion in 2025 to $12.52 billion in 2026 at a compound annual growth rate (CAGR) of 16.4%. The growth in the historic period can be attributed to limitations of tissue biopsy procedures, increasing incidence of lung and breast cancer, early adoption of molecular cancer diagnostics, growing need for early-stage cancer detection, rising clinical research in oncology diagnostics.

What Is The Liquid Biopsy For Cancer Diagnostics Market Growth Forecast?

The liquid biopsy for cancer diagnostics market size is expected to see rapid growth in the next few years. It will grow to $22.99 billion in 2030 at a compound annual growth rate (CAGR) of 16.4%. The growth in the forecast period can be attributed to expansion of liquid biopsy in routine cancer screening, growing focus on personalized cancer care, increasing adoption in treatment response monitoring, rising investments in cancer diagnostics, expanding use in gastrointestinal and ovarian cancers. Major trends in the forecast period include growing adoption of liquid biopsy in lung cancer diagnosis, rising use of blood-based cancer screening methods, increasing demand for real-time cancer monitoring, expansion of liquid biopsy across multiple cancer types, rising clinical preference for minimally invasive diagnostics.

Book your 30 minutes free consultation with our research experts

Global Liquid Biopsy For Cancer Diagnostics Market Segmentation

1) By Type: Product, Services

2) By Sample: Blood, Urine, Saliva

3) By Cancer: Lung Cancer, Breast Cancer, Colon Cancer, Other Cancers

4) By End-User: Hospitals, Diagnostic Centers, Other End-Users

Subsegments:

1) By Product: Circulating Tumor Cells (CTCs) Detection Kits, Circulating Tumor DNA (ctDNA) Detection Kits, Exosome Isolation Kits, Sample Collection Devices

2) By Services: Testing Services, Analytical Services, Bioinformatics Services

What Is The Driver Of The Liquid Biopsy For Cancer Diagnostics Market?

The rising incidence of cancer is expected to propel the growth of the liquid biopsy for cancer diagnostics market going forward. Cancer is a broad category of illnesses that can develop in nearly any organ or tissue in the body when aberrant cells proliferate uncontrollably, cross their usual boundaries, and either spread to other organs or invade neighboring body parts. Cancer increases the need for diagnostic procedures such as early cancer or tumor recurrence detection, risk assessment for each patient, and therapy monitoring to enable liquid biopsy to depict the full scope of the disease as tumor cells or tumor cell products are released from all metastatic or primary tumor sites, providing thorough and real-time information on tumor cell evolution, therapeutic targets, and mechanisms of therapy resistance. For instance, in May 2024, according to the National Cancer Institute, a US-based government agency, there were about 18.1 million cancer survivors in the United States. This figure is projected to rise to 22.5 million by 2032. By 2040, it's expected that the number of new cancer cases each year will reach 29.9 million, with cancer-related deaths estimated to increase to 15.3 million. Therefore, the rising incidence of cancer is driving the growth of the liquid biopsy for cancer diagnostics industry.

Key Players In The Global Liquid Biopsy For Cancer Diagnostics Market

Major companies operating in the liquid biopsy for cancer diagnostics market are F. Hoffman La Roche Ltd., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Illumina Inc., The Menarini Group, Bio-Rad Laboratories Inc., QIAGEN Inc., Exact Sciences Corporation, Bio-Techne Corporation, ArcherDX Inc., Neogenomics Laboratories Inc., Guardant Health Inc., Myriad Genetics Inc., Foundation Medicine Inc., Amoy Diagnostics Co. Ltd., Biocartis Group NV, Biodesix Inc., MDx Health Inc., Sysmex Inostics Inc., Biocept Inc., Agena Bioscience Inc., Laboratory for Advanced Medicine (LAM) Inc., MiRXES Pte Ltd., Inivata Limited, Resolution Bioscience Inc., SAGA Diagnostics AB, NuProbe Inc., Personal Gemone Diagnostics Inc., Pathway Genomics Corporation, Angle PLC

Global Liquid Biopsy For Cancer Diagnostics Market Trends and Insights

Major companies operating in the liquid biopsy for cancer diagnostics market are concentrating their efforts towards developing innovative solutions such as advanced liquid biopsy assays. An advanced liquid biopsy assay refers to a sophisticated and highly refined diagnostic test that analyzes various components present in a liquid biological sample, such as blood or other bodily fluids, to detect and characterize specific biomarkers associated with cancer or other diseases. For instance, in November 2023, Illumina Inc., a US-based global leader in DNA sequencing, announced the launch of ‘TruSight Oncology 500 ctDNA v2 (TSO 500 ctDNA v2)’. It is a research assay designed to facilitate noninvasive comprehensive genomic profiling (CGP) of circulating tumor DNA (ctDNA) extracted from blood. The TSO 500 ctDNA v2 assay is designed to simplify integration for users and enhance the depth of insights available for cancer research.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Liquid Biopsy For Cancer Diagnostics Market?

In February 2024, Veracyte Inc., a US-based diagnostics company, acquired C2i Genomics Inc. for approximately US$70 million. With this acquisition, Veracyte aims to enhance its cancer-diagnostics platform by integrating C2i’s whole-genome minimal residual disease (MRD) detection technology to extend its reach across the cancer-care continuum, improve early detection and recurrence monitoring, and deliver deeper insights for clinicians and patients. C2i Genomics Inc. is a US-based biotechnology company that specializes in AI-enabled whole-genome MRD testing.

Regional Outlook

North America was the largest region in the liquid biopsy for cancer diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the liquid biopsy for cancer diagnostics market report during the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Liquid Biopsy For Cancer Diagnostics Market?

The liquid biopsy for cancer diagnostics market includes revenues earned by entities by providing tumor detection, test validation, and clinical utility. The market value includes the value of related goods sold by the service provider or included within the service offering. The liquid biopsy for cancer diagnostics markets also includes sales of instruments, reagent kits, and liquid biopsy kits, which are used in providing liquid biopsy services. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Liquid Biopsy For Cancer Diagnostics Market Report 2026?

The liquid biopsy for cancer diagnostics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the liquid biopsy for cancer diagnostics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Liquid Biopsy For Cancer Diagnostics Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$12.52 billion
Revenue Forecast In 2035	$22.99 billion
Growth Rate	CAGR of 16.4% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Type, Sample, Cancer, End-User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	F. Hoffman La Roche Ltd., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Illumina Inc., The Menarini Group, Bio-Rad Laboratories Inc., QIAGEN Inc., Exact Sciences Corporation, Bio-Techne Corporation, ArcherDX Inc., Neogenomics Laboratories Inc., Guardant Health Inc., Myriad Genetics Inc., Foundation Medicine Inc., Amoy Diagnostics Co. Ltd., Biocartis Group NV, Biodesix Inc., MDx Health Inc., Sysmex Inostics Inc., Biocept Inc., Agena Bioscience Inc., Laboratory for Advanced Medicine (LAM) Inc., MiRXES Pte Ltd., Inivata Limited, Resolution Bioscience Inc., SAGA Diagnostics AB, NuProbe Inc., Personal Gemone Diagnostics Inc., Pathway Genomics Corporation, Angle PLC
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Liquid Biopsy For Cancer Diagnostics Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Liquid Biopsy For Cancer Diagnostics Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Liquid Biopsy For Cancer Diagnostics Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Liquid Biopsy For Cancer Diagnostics Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Growing Adoption Of Liquid Biopsy In Lung Cancer Diagnosis

4.2.2 Rising Use Of Blood-Based Cancer Screening Methods

4.2.3 Increasing Demand For Real-Time Cancer Monitoring

4.2.4 Expansion Of Liquid Biopsy Across Multiple Cancer Types

4.2.5 Rising Clinical Preference For Minimally Invasive Diagnostics

5. Liquid Biopsy For Cancer Diagnostics Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Diagnostic Centers

5.3 Cancer Treatment Centers

5.4 Academic And Research Institutes

5.5 Biotechnology Companies

6. Liquid Biopsy For Cancer Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Liquid Biopsy For Cancer Diagnostics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Liquid Biopsy For Cancer Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Liquid Biopsy For Cancer Diagnostics Market Size, Comparisons And Growth Rate Analysis

7.3. Global Liquid Biopsy For Cancer Diagnostics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Liquid Biopsy For Cancer Diagnostics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Liquid Biopsy For Cancer Diagnostics Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Liquid Biopsy For Cancer Diagnostics Market Segmentation

9.1. Global Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Product, Services

9.2. Global Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Blood, Urine, Saliva

9.3. Global Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Lung Cancer, Breast Cancer, Colon Cancer, Other Cancers

9.4. Global Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Diagnostic Centers, Other End-Users

9.5. Global Liquid Biopsy For Cancer Diagnostics Market, Sub-Segmentation Of Product, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Circulating Tumor Cells (CTCs) Detection Kits, Circulating Tumor DNA (ctDNA) Detection Kits, Exosome Isolation Kits, Sample Collection Devices

9.6. Global Liquid Biopsy For Cancer Diagnostics Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Testing Services, Analytical Services, Bioinformatics Services

10. Liquid Biopsy For Cancer Diagnostics Market Regional And Country Analysis

10.1. Global Liquid Biopsy For Cancer Diagnostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Liquid Biopsy For Cancer Diagnostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Liquid Biopsy For Cancer Diagnostics Market

11.1. Asia-Pacific Liquid Biopsy For Cancer Diagnostics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Segmentation By Sample, Segmentation By Cancer, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Liquid Biopsy For Cancer Diagnostics Market

12.1. China Liquid Biopsy For Cancer Diagnostics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Segmentation By Sample, Segmentation By Cancer, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Liquid Biopsy For Cancer Diagnostics Market

13.1. India Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Segmentation By Sample, Segmentation By Cancer, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Liquid Biopsy For Cancer Diagnostics Market

14.1. Japan Liquid Biopsy For Cancer Diagnostics Market Overview

14.2. Japan Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Segmentation By Sample, Segmentation By Cancer, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Liquid Biopsy For Cancer Diagnostics Market

15.1. Australia Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Segmentation By Sample, Segmentation By Cancer, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Liquid Biopsy For Cancer Diagnostics Market

16.1. Indonesia Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Segmentation By Sample, Segmentation By Cancer, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Liquid Biopsy For Cancer Diagnostics Market

17.1. South Korea Liquid Biopsy For Cancer Diagnostics Market Overview

17.2. South Korea Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Segmentation By Sample, Segmentation By Cancer, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Liquid Biopsy For Cancer Diagnostics Market

18.1. Taiwan Liquid Biopsy For Cancer Diagnostics Market Overview

18.2. Taiwan Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Segmentation By Sample, Segmentation By Cancer, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Liquid Biopsy For Cancer Diagnostics Market

19.1. South East Asia Liquid Biopsy For Cancer Diagnostics Market Overview

19.2. South East Asia Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Segmentation By Sample, Segmentation By Cancer, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Liquid Biopsy For Cancer Diagnostics Market

20.1. Western Europe Liquid Biopsy For Cancer Diagnostics Market Overview

20.2. Western Europe Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Segmentation By Sample, Segmentation By Cancer, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Liquid Biopsy For Cancer Diagnostics Market

21.1. UK Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Segmentation By Sample, Segmentation By Cancer, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Liquid Biopsy For Cancer Diagnostics Market

22.1. Germany Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Segmentation By Sample, Segmentation By Cancer, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Liquid Biopsy For Cancer Diagnostics Market

23.1. France Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Segmentation By Sample, Segmentation By Cancer, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Liquid Biopsy For Cancer Diagnostics Market

24.1. Italy Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Segmentation By Sample, Segmentation By Cancer, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Liquid Biopsy For Cancer Diagnostics Market

25.1. Spain Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Segmentation By Sample, Segmentation By Cancer, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Liquid Biopsy For Cancer Diagnostics Market

26.1. Eastern Europe Liquid Biopsy For Cancer Diagnostics Market Overview

26.2. Eastern Europe Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Segmentation By Sample, Segmentation By Cancer, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Liquid Biopsy For Cancer Diagnostics Market

27.1. Russia Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Segmentation By Sample, Segmentation By Cancer, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Liquid Biopsy For Cancer Diagnostics Market

28.1. North America Liquid Biopsy For Cancer Diagnostics Market Overview

28.2. North America Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Segmentation By Sample, Segmentation By Cancer, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Liquid Biopsy For Cancer Diagnostics Market

29.1. USA Liquid Biopsy For Cancer Diagnostics Market Overview

29.2. USA Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Segmentation By Sample, Segmentation By Cancer, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Liquid Biopsy For Cancer Diagnostics Market

30.1. Canada Liquid Biopsy For Cancer Diagnostics Market Overview

30.2. Canada Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Segmentation By Sample, Segmentation By Cancer, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Liquid Biopsy For Cancer Diagnostics Market

31.1. South America Liquid Biopsy For Cancer Diagnostics Market Overview

31.2. South America Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Segmentation By Sample, Segmentation By Cancer, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Liquid Biopsy For Cancer Diagnostics Market

32.1. Brazil Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Segmentation By Sample, Segmentation By Cancer, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Liquid Biopsy For Cancer Diagnostics Market

33.1. Middle East Liquid Biopsy For Cancer Diagnostics Market Overview

33.2. Middle East Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Segmentation By Sample, Segmentation By Cancer, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Liquid Biopsy For Cancer Diagnostics Market

34.1. Africa Liquid Biopsy For Cancer Diagnostics Market Overview

34.2. Africa Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Segmentation By Sample, Segmentation By Cancer, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Liquid Biopsy For Cancer Diagnostics Market Regulatory and Investment Landscape

36. Liquid Biopsy For Cancer Diagnostics Market Competitive Landscape And Company Profiles

36.1. Liquid Biopsy For Cancer Diagnostics Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Liquid Biopsy For Cancer Diagnostics Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Liquid Biopsy For Cancer Diagnostics Market Company Profiles

36.3.1. F. Hoffman La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. The Menarini Group Overview, Products and Services, Strategy and Financial Analysis

37. Liquid Biopsy For Cancer Diagnostics Market Other Major And Innovative Companies

Bio-Rad Laboratories Inc., QIAGEN Inc., Exact Sciences Corporation, Bio-Techne Corporation, ArcherDX Inc., Neogenomics Laboratories Inc., Guardant Health Inc., Myriad Genetics Inc., Foundation Medicine Inc., Amoy Diagnostics Co. Ltd., Biocartis Group NV, Biodesix Inc., MDx Health Inc., Sysmex Inostics Inc., Biocept Inc.

38. Global Liquid Biopsy For Cancer Diagnostics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Liquid Biopsy For Cancer Diagnostics Market

40. Liquid Biopsy For Cancer Diagnostics Market High Potential Countries, Segments and Strategies

40.1 Liquid Biopsy For Cancer Diagnostics Market In 2030 - Countries Offering Most New Opportunities

40.2 Liquid Biopsy For Cancer Diagnostics Market In 2030 - Segments Offering Most New Opportunities

40.3 Liquid Biopsy For Cancer Diagnostics Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Liquid Biopsy For Cancer Diagnostics Market, Overview Of Key Products - Product Examples

Table 2: Global Liquid Biopsy For Cancer Diagnostics Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Liquid Biopsy For Cancer Diagnostics Market, Supply Chain Analysis

Table 4: Global Liquid Biopsy For Cancer Diagnostics Market, Major Raw Material Providers

Table 5: Global Liquid Biopsy For Cancer Diagnostics Market, Major Resource Providers

Table 6: Global Liquid Biopsy For Cancer Diagnostics Market, Major Manufacturers (Suppliers)

Table 7: Global Liquid Biopsy For Cancer Diagnostics Market, Major Distributors And Channel Partners

Table 8: Global Liquid Biopsy For Cancer Diagnostics Market, Key Technologies & Future Trends

Table 9: Global Liquid Biopsy For Cancer Diagnostics Market, Major Trends

Table 10: Global Liquid Biopsy For Cancer Diagnostics Market, Major End Users

Table 11: Global Liquid Biopsy For Cancer Diagnostics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Liquid Biopsy For Cancer Diagnostics Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Liquid Biopsy For Cancer Diagnostics Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Liquid Biopsy For Cancer Diagnostics Market - TAM, US$ Billion, 2025

Table 15: Global Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Liquid Biopsy For Cancer Diagnostics Market, Sub-Segmentation Of Product, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Liquid Biopsy For Cancer Diagnostics Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Liquid Biopsy For Cancer Diagnostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Liquid Biopsy For Cancer Diagnostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Asia-Pacific, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Asia-Pacific, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: China, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: China, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: India, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: India, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: Japan, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Japan, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Australia, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Australia, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Indonesia, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Indonesia, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: South Korea, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: South Korea, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: Taiwan, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Taiwan, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: South East Asia, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: South East Asia, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: Western Europe, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Western Europe, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: UK, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: UK, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: Germany, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: Germany, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: France, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: France, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: Italy, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: Italy, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Spain, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Spain, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Eastern Europe, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Eastern Europe, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Russia, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Russia, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: North America, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: North America, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: USA, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: USA, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: Canada, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: Canada, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: South America, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: South America, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: Brazil, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: Brazil, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Middle East, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Middle East, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Africa, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Africa, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Global Liquid Biopsy For Cancer Diagnostics Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 96: Global Liquid Biopsy For Cancer Diagnostics Market - Company Scoring Matrix

Table 97: F. Hoffman La Roche Ltd. Financial Performance

Table 98: Thermo Fisher Scientific Inc. Financial Performance

Table 99: Agilent Technologies Inc. Financial Performance

Table 100: Illumina Inc. Financial Performance

Table 101: The Menarini Group Financial Performance

Table 102: Global Liquid Biopsy For Cancer Diagnostics Market, Competitive Benchmarking (In USD Billions)

Table 103: Global Liquid Biopsy For Cancer Diagnostics Market, Competitive Dashboard

Table 104: Global Liquid Biopsy For Cancer Diagnostics Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 105: Global, Liquid Biopsy For Cancer Diagnostics Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Table 106: Global, Liquid Biopsy For Cancer Diagnostics Market Size Gain ($ Billion), Segmentation By Sample, 2025 – 2030

Table 107: Global, Liquid Biopsy For Cancer Diagnostics Market Size Gain ($ Billion), Segmentation By Cancer, 2025 – 2030

List Of Figures

Figure 1: Global Liquid Biopsy For Cancer Diagnostics Market, Overview Of Key Products - Product Examples

Figure 2: Global Liquid Biopsy For Cancer Diagnostics Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Liquid Biopsy For Cancer Diagnostics Market, Supply Chain Analysis

Figure 4: Global Liquid Biopsy For Cancer Diagnostics Market, Major Raw Material Providers

Figure 5: Global Liquid Biopsy For Cancer Diagnostics Market, Major Resource Providers

Figure 6: Global Liquid Biopsy For Cancer Diagnostics Market, Major Manufacturers (Suppliers)

Figure 7: Global Liquid Biopsy For Cancer Diagnostics Market, Major Distributors And Channel Partners

Figure 8: Global Liquid Biopsy For Cancer Diagnostics Market, Key Technologies & Future Trends

Figure 9: Global Liquid Biopsy For Cancer Diagnostics Market, Major Trends

Figure 10: Global Liquid Biopsy For Cancer Diagnostics Market, Major End Users

Figure 11: Global Liquid Biopsy For Cancer Diagnostics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Liquid Biopsy For Cancer Diagnostics Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Liquid Biopsy For Cancer Diagnostics Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Liquid Biopsy For Cancer Diagnostics Market - TAM, US$ Billion, 2025

Figure 15: Global Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Liquid Biopsy For Cancer Diagnostics Market, Sub-Segmentation Of Product, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Liquid Biopsy For Cancer Diagnostics Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Liquid Biopsy For Cancer Diagnostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Liquid Biopsy For Cancer Diagnostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Asia-Pacific, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Asia-Pacific, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: China, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: China, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: India, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: India, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: Japan, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Japan, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Australia, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Australia, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Indonesia, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Indonesia, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: South Korea, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: South Korea, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: Taiwan, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Taiwan, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: South East Asia, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: South East Asia, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: Western Europe, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Western Europe, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: UK, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: UK, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: Germany, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: Germany, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: France, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: France, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: Italy, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: Italy, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Spain, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Spain, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Eastern Europe, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Eastern Europe, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Russia, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Russia, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: North America, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: North America, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: USA, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: USA, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: Canada, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: Canada, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: South America, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: South America, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: Brazil, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: Brazil, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Middle East, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Middle East, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Africa, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Africa, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Global Liquid Biopsy For Cancer Diagnostics Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 96: Global Liquid Biopsy For Cancer Diagnostics Market - Company Scoring Matrix

Figure 97: F. Hoffman La Roche Ltd. Financial Performance

Figure 98: Thermo Fisher Scientific Inc. Financial Performance

Figure 99: Agilent Technologies Inc. Financial Performance

Figure 100: Illumina Inc. Financial Performance

Figure 101: The Menarini Group Financial Performance

Figure 102: Global Liquid Biopsy For Cancer Diagnostics Market, Competitive Benchmarking (In USD Billions)

Figure 103: Global Liquid Biopsy For Cancer Diagnostics Market, Competitive Dashboard

Figure 104: Global Liquid Biopsy For Cancer Diagnostics Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 105: Global, Liquid Biopsy For Cancer Diagnostics Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Figure 106: Global, Liquid Biopsy For Cancer Diagnostics Market Size Gain ($ Billion), Segmentation By Sample, 2025 – 2030

Figure 107: Global, Liquid Biopsy For Cancer Diagnostics Market Size Gain ($ Billion), Segmentation By Cancer, 2025 – 2030

Global Outpatient Clinics Market Forecast to Reach $53.81 Billion by 2029, Driven by 5.3% CAGR

Outpatient Home Therapy Industry Poised for Rapid Expansion, Projected to Hit $72.97 Billion by 2029

In-Depth Outpatient Oncology Infusion Market Report: Business Trends, Growth Factors, and Forecast to 2029

2025 Analysis: Opportunities and Risks in the Evolving Outpatient Rehabilitation Services Market

Explore future trends in the global pharma and biotech CRM software market. Understand market growth, drivers, and industry outlook through 2034.

Explore market drivers and forecast in the nasal spray influenza vaccine sector through 2025–2034.

Review key data-driven trends shaping the global data storage market in 2025.

Analyze the 6.7% CAGR growth trajectory and strategic trends shaping the global medical glass vaccine bottles market through 2029.

Liquid Biopsy Market Report 2026 - Global Outlook – By Product (Assay Kits, Instruments, Services ), By Clinical Application (Early Cancer Screening, Therapy Selection, Treatment Monitoring, Recurrence Monitoring), By En...

Biopsy Devices Market Report 2026 - Global Outlook – By Product Type (Needle-Based Biopsy Guns, Biopsy Forceps, Biopsy Guidance Systems, Biopsy Needles, Other Products), By Image Guiding Technology (MRI-Guided Biopsy, St...

Cancer Diagnostics Market Report 2026 - Global Outlook – By Products (Companion Diagnostics, Molecular Diagnostics), By Method (Biopsy, Endoscopy, Tumor Biomarker Tests, Imaging), By Application (Cervical Cancer, Breast ...

Biopsy Devices Market Report 2026 - Global Outlook – By Product Type (Needle-Based Biopsy Guns, Biopsy Forceps, Biopsy Guidance Systems, Biopsy Needles, Other Products), By Image Guiding Technology (MRI-Guided Biopsy, St...

Mobile Artificial Intelligence Market Report 2026 - Global Outlook – By Component (Hardware, Software, Services), By Technology Node (20–28 Nano Meter (NM), 10 Nano Meter (NM), 7 Nano Meter (NM), Other Technology Nodes),...

Biomedical Textiles Market Report 2026 - Global Outlook – By Product Type (Non Implantable, Implantable), By Fabric (Non-Woven Biomedical Textiles, Woven Biomedical Textiles, Knitted Biomedical Textiles), By Fiber Type (...

Breast Cancer Diagnostics Market Report 2026 - Global Outlook – By Type (Imaging, Biopsy, Genomic Tests, Blood Tests, Other Types), By Technology (Fluorescent In Situ Hybridization (FISH), Comparative Genomic Hybridizati...

Frequently Asked Questions

How big is the Liquid Biopsy For Cancer Diagnostics Market?

The Liquid Biopsy For Cancer Diagnostics market was valued at $10.75 billion in 2025, increased to $12.52 billion in 2026, and is projected to reach $22.99 billion by 2030.

What is the Liquid Biopsy For Cancer Diagnostics market growth?

The global Liquid Biopsy For Cancer Diagnostics market is expected to grow at a CAGR of 16.4% from 2026 to 2035 to reach $22.99 billion by 2035.

Who are the key players in Liquid Biopsy For Cancer Diagnostics market?

Some Key Players in the Liquid Biopsy For Cancer Diagnostics market Include, F. Hoffman La Roche Ltd., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Illumina Inc., The Menarini Group, Bio-Rad Laboratories Inc., QIAGEN Inc., Exact Sciences

Major trend in this market includes: Innovative Liquid Biopsy Solutions Revolutionizing Cancer Detection and Research. For further insights on this market. request a sample here

North America was the largest region in the liquid biopsy for cancer diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the liquid biopsy for cancer diagnostics market report during the forecast period.

Book your 30 minutes free consultation with our research experts

Contact Us